Molecular Testing

You are here

Molecular Testing

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

,
,
,
,
Molecular Diagnostics Testing and Next Generation Sequencing
The Global Resource for Advancing Cancer Education (GRACE), presents Molecular Diagnostic Testing and Next Generation Sequencing in Lung Cancer webinar series.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Molecular Testing
Lung Cancer Video Library - Patterns of Resistance in ALK Positive NSCLC
Dr. Alice Shaw joined GRACE to discuss patterns of resistance in ALK positive non small cell lung cancer.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies – ALK, Biopsy/Tissue Collection, Tumor Marker Tests, Molecular Testing, Second-line treatment
Lung Cancer Video Library 2017 - New Options in Acquired Resistance for ALK Positive Non-small Cell Lung Cancer (NSCLC)
Nathan Pennell, MD, PhD, Director of Lung Cancer Medical Oncology at the Cleveland Clinic Taussig Cancer Center in Cleveland Ohio discusses new options in acquired resistance for ALK positive non-small cell lung cancer (NSCLC).
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Tumor Marker Tests, Targeted Therapy, Molecular Testing, Second-line treatment, Targeted Therapies – ALK
,
,
Targeted Therapies in Lung Cancer Patient Forum 2017 - Presentations and Handouts
Download the speaker presentations and handouts from the Targeted Therapies Patient Forum in Cleveland at the Taussig Cancer Center on September 16, 2017.
Cancer Journey:
Just Diagnosed, In Treatment, Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Tumor Marker Tests, 3rd Line and beyond, Targeted Therapy, Molecular Testing, First-line treatment, Scans - PET-CT, etc., Second-line treatment, Clinical Trials, Non Small Cell Lung Cancer
Lung Cancer Video Library - Liquid Biopsies for Broad Next Generation Sequencing Testing
Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International University discusses Liquid Biopsies for Broad Next Generation Sequencing Testing.
Cancer Journey:
In Treatment, Just Diagnosed
Cancer Type:
Lung Cancer
Disease Learning:
Molecular Testing

Articles

Can Immunotherapy Play a Role in Locally Advanced NSCLC?
Dr. Nasser Hanna, Indiana University Health, discusses the possible role of immunotherapy in locally advanced NSCLC.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Molecular Testing, Targeted Therapy, Symptoms
HER2 Mutation Positive NSCLC
Dr. Nathan Pennell, Cleveland Clinic, describes treatment of NSCLC patients with HER2 mutations using agents such as Gilotrif or Herceptin.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
First-line treatment, Molecular Testing, Targeted Therapy, Maintenance Therapy, Second-line treatment
ALK Inhibitors for Acquired Resistance: Zykadia and Alectinib
Dr. Nathan Pennell, Cleveland Clinic, discusses acquired resistance to Xalkori in ALK-positive patients, and second generation inhibitors designed to overcome that resistance, such as Zykadia and alectinib.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, Molecular Testing, Maintenance Therapy, Second-line treatment, 3rd Line and beyond
Combinations and Other Options for Acquired Resistance in EGFR Mutation-Positive NSCLC
Dr. Nathan Pennell, Cleveland Clinic, describes other options for treatment of acquired resistance, including chemotherapy, ablation with SBRT and a combination of Gilotrif and Erbitux.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, Chemotherapy, Molecular Testing, Maintenance Therapy, Radiation Therapy, Second-line treatment, 3rd Line and beyond
Third Generation EGFR TKIs for Acquired Resistance
Dr. Nathan Pennell, Cleveland Clinic, discusses the concept of acquired resistance and new agents designed to address it, including Rociletinib and Merelitinib.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, Molecular Testing, Second-line treatment

Community Forum

No Result Found